Dermtube Videos
DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More
Series: DermWire TV | October 10, 2019
In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses her experience. Sandy Klein, co-trustee of the Lynn Waxman Foundation, is this year’s Skin Cancer Foundation Champions for Change Honoree. The Hacking Dermatology 2019 Hackathon puts innovation front and center.
Close Up: Exploring New Research in Metastatic Melanoma
Video | October 3, 2019
Adil Daud, MD discusses the promising results of a new study looking at the use of Tafinlar (dabrafenib) and Mekinist (trametinib) in BRAF-mutated advanced melanoma.
Ask an Expert: What Do We Know about QoL in Hidradenitis Suppurativa
Series: Ask an Expert | September 27, 2019
With a surge in new research over the last decade, dermatologists are learning more about Hidradenitis Suppurativa, comorbidities, and quality of life impact. In the first of a series, Steven Cohen, MD discusses HS with host Adam Friedman, MD.
Atopic Dermatitis: The Critical Need for Treatment
Series: Eczema Awareness 2019 | September 25, 2019
The therapeutic landscape for atopic dermatitis is expanding, as is understanding of the disease and its impact. More than ever, patients need access to effective therapies and meaningful symptom control strategies, says Adam J. Friedman, MD.
Atopic Dermatitis: Understanding the Impact
Series: Eczema Awareness 2019 | September 25, 2019
For most AD patients, eczema is a bumpy ride. Even mild cases of atopic dermatitis can have a significant effect on people—and these effects range from quality of life impact to treatment costs. Peter Lio, MD describes his approach to a long-term eczema management plan.
Meeting Coverage
